Spider venom treatment for heart attacks progressing to trials
07 July, 2022The drug candidate uses a molecule found in the venom of the K’gari funnel-web spider, and can potentially prevent damage caused by heart attacks and stroke.
Existing drug may help treat spinal cord injury
17 June, 2022Scientists have shown that an existing drug may reduce damage after spinal cord injury (SCI), by blocking the inflammatory response in the spinal cord.
Human ear reconstructed with 3D-bioprinted implant
08 June, 2022AuriNovo is a patient-specific, living tissue implant created using 3D-bioprinting technology for surgical reconstruction of the outer ear in people born with microtia.
Damaged liver repaired, transplanted after 3 days outside body
06 June, 2022Liver4Life reports the successful treatment of a damaged human liver for three days outside of the body, with implantation of the recovered organ into a cancer patient.
Wireless neurostimulator like a pacemaker for the brain
24 May, 2022Neurological disorders like Parkinson's, chronic depression and other psychiatric conditions can now be managed at home.
Bringing clinical trials to the home: a game changer for the sector
23 May, 2022 by Edwin Ng, Senior Vice-President, Asia-Pacific for Medidata, a Dassault Systèmes companyCOVID-19 has forced Australia's pharmaceutical and healthcare companies to completely redesign how clinical trials are run.
How do antidepressants treat nerve pain?
04 May, 2022Knowing how pain impulses are inhibited by tricyclic antidepressants is expected to lead to new and improved treatment options.
Biobanking could save koalas from extinction
26 April, 2022Biobanking and assisted reproduction could become a reality for koalas by leveraging the existing technology used to help humans conceive.
CA inhibitor drug reduces breathing pauses in sleep apnoea
21 April, 2022Overall, the treatment reduced the number of breathing pauses and promoted oxygenation during the night.
Accelerating Australia's RNA Capabilities
19 April, 2022It is one thing to invest into pure research, but to invest in a future that has, at its core, collaboration and accelerated development is a giant leap.
Creating a genetic medicine manufacturing ecosystem: part 3
07 April, 2022 by Peter DavisA year ago, we were waiting for the federal government to deliver funding and a plan forward for a genetic medicine ecosystem.
'Trojan Horse' drug delivery system developed
05 April, 2022Scientists created a method of delivering drugs into human cells using large biological molecules by first encasing them in a protein-based microdroplet.
Clinical trial commences for Melbourne-made COVID vaccines
29 March, 2022Researchers are looking for 114 healthy people aged 18–70 living in Victoria to roll up their sleeves for a Phase 1 clinical trial of two Melbourne-made COVID-19 vaccines.
Winter COVID booster for at-risk groups, Vic to make mRNA vaccines
25 March, 2022ATAGI recommends an additional booster dose of COVID-19 vaccine for vulnerable population groups, and Moderna agrees to produce up to 100 million Australian-made mRNA vaccine doses every year.
CRISPR cancer therapy doesn't kill healthy cells
14 March, 2022Researchers have combined the concepts of cancer genomics and CRISPR-Cas9 to propose a cancer therapy that kills cancer cells without affecting normal tissues.
